The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 pSivida Ltd.  (PSDV) Trade Now »     Rate PSDV  -  Discuss PSDV  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate PSDV:



PSDV Analysis & Videos »


PSDV: Bull or Bear?

Extreme FDA Calendar Trades: 18 Stocks Under $5 Graphic_rating_buy PSDV
Mikerun
73%
 +105.65%
in 156 days
<> Below are extreme trades among companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> , which includes 232 entries as of 7/3/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissio...
By  Mike Havrilla   (+1.04%  risk: conservative)  07/03/09 Comment


BioMedReports FDA Calendar: Seven New Extreme Trades Graphic_rating_buy PSDV
Mikerun
73%
 -9.23%
in 16 days
(closed on 07/03/09)
<> Below are companies with market caps under $250 million from the <font> BioMedReports.com FDA Calendar </font> , which have either pending FDA decisions or pending clinical trial results that may have a major impact on each of the underlying stock prices. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in <font> Extreme FDA and Clinical Trial Calendar Trades </font> , which are highlighted in periodic articles at BioMedReports.com. Another approach is to simply ...
By  Mike Havrilla   (+1.04%  risk: conservative)  06/17/09 Comment


Updated FDA, Clinical Trial Calendars: AZN, MYGN, NVS, PSDV Graphic_rating_buy PSDV
Mikerun
73%
 +77.27%
in 70 days
(closed on 06/17/09)
Below is a summary of updates to the BioMedReports.com database of 240 entries included in the FDA and Clinical Trial Calendars .
 
 
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 113 entries through 4/8/09. The FDA Calendar includes the following information: company name, ticker, decision ...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/08/09 Comment


Get free stock alert for PSDV:
Your Email Address:





People Bullish on PSDV

Mikerun
Mike Havrilla
Principal
73%
5 mos ago


People Bearish on PSDV

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
MA MasterCard Inc
LEH Lehman Brothers Holdings Inc
PG The Procter & Gamble Company
WM Washington Mutual Inc
T AT&T Inc
DRYS DryShips Inc.

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on PSDV


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About pSivida Ltd. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch